Answer:
Access to safe and effective medical products
Clinical trial transparency
protecting vulnerable populations
Step-by-step explanation:
Access to safe and effective medical products: The FDA is responsible for ensuring that drugs, medical devices, and other products are safe and effective for use by the public. This includes ensuring access to medical products for all individuals, regardless of their race, ethnicity, or other personal characteristics.
Clinical trial transparency: The FDA is committed to increasing transparency in clinical trials and ensuring that the results of these trials are widely available to the public. This is important for both promoting scientific progress and protecting the rights of human subjects in clinical trials.
Protecting vulnerable populations: The FDA is committed to protecting the rights of vulnerable populations, such as children, pregnant women, and elderly individuals, who may be more susceptible to the risks associated with medical products. The FDA has policies in place to ensure that these populations are not subjected to unnecessary harm from medical products.